851690-75-0

Basic information

• Product Name: 3-Pyrrolidinol, 1-(2-methoxy-4-nitrophenyl)-, (3R)-
• CAS NO: 851690-75-0
• Molecular Formula: C11H14N2O4
• Molecular Weight: 238.243
• Mol File: 851690-75-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 3-Pyrrolidinol, 1-(2-methoxy-4-nitrophenyl)-, (3R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyrrolidinol, 1-(2-methoxy-4-nitrophenyl)-, (3R)-(851690-75-0)
• EPA Substance Registry System: 3-Pyrrolidinol, 1-(2-methoxy-4-nitrophenyl)-, (3R)-(851690-75-0)

Safety Data

• Hazardous Substances Data: 851690-75-0(Hazardous Substances Data)

Upstream product

• 40499-83-0 pyrrolidin-3-ol 
• 1009-36-5 2-chloro-5-nitroanisole 
• 40499-83-0 (3R)-pyrrolidinol 

Downstream Products

• 892870-69-8 (R)-1-(2-methoxy-4-nitro-phenyl)-3-triisopropylsilanyloxy-pyrrolidine 
• 851690-80-7 (R)-3-(methyloxy)-1-[2-(methyloxy)-4-nitrophenyl]pyrrolidine 
• 1221420-45-6 (S)-((R)-1-(2-methoxy-4-nitrophenyl)pyrrolidin-3-yl) 2-(tert-butoxycarbonylamino)-3-methylbutanoate 
• 851690-21-6 6-(4-chlorophenyl)-3-{4-[(3R)-3-hydroxypyrrolidin-1-yl]-3-methoxyphenyl}thieno[3, 2-d]pyrimidin-4(3H)-one 
• 921592-79-2 (3R)-1-(4-amino-2-methoxyphenyl)pyrrolidin-3-ol 

Relevant articles and documents

AZOLOPYRROLONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS

The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula (I) including all pharmaceutically acceptable salts and stereoisomers thereof: wherein A is a mo

NOVEL MCH RECEPTOR ANTAGONISTS

The present invention relates to a melanin concentrating hormone antagonist compound of formula (I): wherein R1, Ra, Rb, R2, L1, R3, R4 and R5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diasteromers thereof useful in the treatment, obesity and related diseases.

3-(4-AMINOPHENYL) THIENOPYRIMID-4-ONE DERIVATIVES AS MCH R1 ANTAGONISTS FOR THE TREATMENT OF OBESITY, DIABETES, DEPRESSION AND ANXIETY

This invention relates to novel arylamines which are antagonists of the melanin-concentrating hormone receptor 1 (MCH R1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines for the treatment